A pilot study regarding efficacy and safety of combination therapy with angiotensin receptor blocker and renin inhibitor for patients with chronic heart failure combined with hypertension and diabetes
Not Applicable
Recruiting
- Conditions
- Chronic heart failure combined with hypertension and diabetes
- Registration Number
- JPRN-UMIN000004059
- Lead Sponsor
- Osaka Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Within 24 weeks after initiation of statin, fibrates, or diabetes drug other than insulin 2. Within 24 weeks after onset of acute myocardial infarction 3. Within 12 weeks after onset of stroke 4. Severe ventricular arrhythmia or AV block (second or third degree) 5. Cardiogenic shock 6. Secondary hypertension other than renal hypertension 7. Bilateral renal artery stenosis 8. Hypertensive emergency including malignant hypertension 9. Severe liver damage 10. Severe hemopoietic disorder or malignancy 11. Type 1 diabetes 12. During Cyclosporine administration 13. During pregnancy or lactation. Woman of child-bearing potential
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method